Search Results - Tor D. Tosteson
- Showing 1 - 4 results of 4
-
1
A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia by Darcy B. Pooler, Dylan B. Ness, Alexey V. Danilov, Bridget M. Labrie, Tor D. Tosteson, Alan Eastman, Lionel D. Lewis, Frederick Lansigan
Published in eJHaem (2022-11-01)Get full text
Article -
2
Adoption of Telemedicine in a Rural US Cancer Center Amid the COVID-19 Pandemic: Qualitative Study by Matthew Mackwood, Rebecca Butcher, Danielle Vaclavik, Jennifer A Alford-Teaster, Kevin M Curtis, Mary Lowry, Tor D Tosteson, Wenyan Zhao, Anna N A Tosteson
Published in JMIR Cancer (2022-08-01)Get full text
Article -
3
Peer review of clinical and translational research manuscripts: Perspectives from statistical collaborators by Phillip J. Schulte, Judith D. Goldberg, Robert A. Oster, Walter T. Ambrosius, Lauren Balmert Bonner, Howard Cabral, Rickey E. Carter, Ye Chen, Manisha Desai, Dongmei Li, Christopher J. Lindsell, Gina-Maria Pomann, Emily Slade, Tor D. Tosteson, Fang Yu, Heidi Spratt
Published in Journal of Clinical and Translational Science (2024-01-01)Get full text
Article -
4
Guidance for biostatisticians on their essential contributions to clinical and translational research protocol review by Jody D. Ciolino, Cathie Spino, Walter T. Ambrosius, Shokoufeh Khalatbari, Shari Messinger Cayetano, Jodi A. Lapidus, Paul J Nietert, Robert A. Oster, Susan M. Perkins, Brad H. Pollock, Gina-Maria Pomann, Lori Lyn Price, Todd W. Rice, Tor D. Tosteson, Christopher J. Lindsell, Heidi Spratt
Published in Journal of Clinical and Translational Science (2021-01-01)Get full text
Article
